Erratum: Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis (Nature Communications (2016) 7 (12460) DOI: 10.1038/ncomms12460);Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis

Nature Communications

Volumn 7, Issue , 2016, Pages

  Sieberts, Solveig K ^a   Zhu, Fan ^b   García García, Javier ^c   Stahl, Eli ^d   Pratap, Abhishek ^a   Pandey, Gaurav ^d   Pappas, Dimitrios ^e,f   Aguilar, Daniel ^c   Anton, Bernat ^c   Bonet, Jaume ^c   Eksi, Ridvan ^b   Fornés, Oriol ^c   Guney, Emre ^g   Li, Hongdong ^b   Marín, Manuel Alejandro ^c   Panwar, Bharat ^b   Planas Iglesias, Joan ^c   Poglayen, Daniel ^c   Cui, Jing ⁱ   Falcao, Andre O ^j   Suver, Christine ^a   Hoff, Bruce ^a   Balagurusamy, Venkat S K ^k   Dillenberger, Donna ^k   Neto, Elias Chaibub ^a   Norman, Thea ^a   Aittokallio, Tero ^k   Ammad Ud Din, Muhammad ^m,n   Azencott, Chloe Agathe ^o,p,q   Bellón, Víctor ^o,p,q   Boeva, Valentina ^o,p,q   Bunte, Kerstin ^m,n   Chheda, Himanshu ^l   Cheng, Lu ^l,m,n   Corander, Jukka ^l,n   Dumontier, Michel ^r   Goldenberg, Anna ^s,t   Gopalacharyulu, Peddinti ^l   Hajiloo, Mohsen ^t   Hidru, Daniel ^s,t   Jaiswal, Alok ^l   Kaski, Samuel ^l,m,n   Khalfaoui, Beyrem ^t   Khan, Suleiman Ali ^l,m,n   Kramer, Eric R ^u   Marttinen, Pekka ^m,n   Mezlini, Aziz M ^s,t   Molparia, Bhuvan ^u   Pirinen, Matti ^l   Saarela, Janna ^l   Samwald, Matthias ^v   Stoven, Véronique ^o,p,q   Tang, Hao ^w   Tang, Jing ^l   Torkamani, Ali ^u   Vert, Jean Phillipe ^o,p,q   Wang, Bo ^x   Wang, Tao ^w   Wennerberg, Krister ^l   Wineinger, Nathan E ^u   Xiao, Guanghua ^w   Xie, Yang ^w,y   Yeung, Rae ^t,z   Zhan, Xiaowei ^w   Zhao, Cheng ^s,t   Greenberg, Jeff ^f,aa   Kremer, Joel ^ab   Michaud, Kaleb ^ac,ad   Barton, Anne ^ae,af   Coenen, Marieke ^ag   Mariette, Xavier ^ah,ai   Miceli, Corinne ^ah,ai   Shadick, Nancy ⁱ   Weinblatt, Michael ⁱ   De Vries, Niek ^aj   Tak, Paul P ^aj,ak,al,am   Gerlag, Danielle ^aj,am   Huizinga, Tom W J ^an   Kurreeman, Fina ^an   Allaart, Cornelia F ^an   Louis Bridges, S ^ao   Criswell, Lindsey ^ap   Moreland, Larry ^aq   Klareskog, Lars ^ar   Saevarsdottir, Saedis ^ar   Padyukov, Leonid ^ar   Gregersen, Peter K ^as   Friend, Stephen ^a   Plenge, Robert ^h   Stolovitzky, Gustavo ^d,j   Oliva, Baldo ^c   Guan, Yuanfang ^b   Mangravite, Lara M ^a   more..

^a SAGE BIONETWORKS   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITAT POMPEU FABRA   (Spain)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

^f Departments of Biostatistics and Epidemiology and Outcomes Research   (United States)

^g NORTHEASTERN UNIVERSITY   (United States)

^h MERCK RESEARCH LABORATORIES   (United States)

ⁱ BRIGHAM AND WOMEN S HOSPITAL   (United States)

^j UNIVERSITY OF LISBON   (Portugal)

^k IBM T J WATSON RESEARCH CENTER   (United States)

^l UNIVERSITY OF HELSINKI   (Finland)

^m AALTO UNIVERSITY   (Finland)

ⁿ HELSINKI INSTITUTE FOR INFORMATION TECHNOLOGY   (Finland)

^o PSL RESEARCH UNIVERSITY   (France)

^p INSTITUT CURIE   (France)

^q INSERM U900   (France)

^r STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^s UNIVERSITY OF TORONTO   (Canada)

^t HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^u SCRIPPS RESEARCH INSTITUTE   (United States)

^v MEDICAL UNIVERSITY OF VIENNA   (Austria)

^w UNIVERSITY OF TEXAS AT DALLAS   (United States)

^x Stanford University   (United States)

^y UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^z UNIVERSITY OF TORONTO   (Canada)

^aa NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ab ALBANY MEDICAL COLLEGE   (United States)

^ac UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^ad NATIONAL DATA BANK FOR RHEUMATIC DISEASES   (United States)

^ae UNIVERSITY OF MANCHESTER   (United Kingdom)

^af MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^ag RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^ah UNIVERSITÉ PARIS SACLAY   (France)

^ai INSERM U1184   (France)

^aj UNIVERSITY OF AMSTERDAM   (Netherlands)

^ak UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^al GHENT UNIVERSITY   (Belgium)

^am GLAXOSMITHKLINE   (United Kingdom)

^an LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^ao The University of Alabama at Birmingham   (United States)

^ap UNIVERSITY OF CALIFORNIA   (United States)

^aq UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^ar KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^as FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CERTOLIZUMAB PEGOL; GOLIMUMAB; INFLIXIMAB; METHOTREXATE; TUMOR NECROSIS FACTOR ANTIBODY; ANTIRHEUMATIC AGENT; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR;

BIOMARKER; DISEASE INCIDENCE; DISEASE TREATMENT; GENETIC STRUCTURE; HERITABILITY; POLYMORPHISM; PREDICTION; PROTEIN; RESEARCH WORK;

ARTICLE; DAS28; DRUG EFFICACY; EXPECTATION; GENOTYPE; HERITABILITY; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PHARMACOGENETICS; PREDICTION; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE; ADULT; AGED; ANTAGONISTS AND INHIBITORS; COHORT ANALYSIS; CROWDSOURCING; FEMALE; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; MALE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; TREATMENT OUTCOME;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CERTOLIZUMAB PEGOL; COHORT STUDIES; CROWDSOURCING; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84984705713     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms13205     Document Type: Erratum

References (48)

1. Gibofsky, A. Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis. Am. J. Manag. Care 18, S295-S302 (2012).
2. McInnes, I. B. & Schett, G. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 365, 2205-2219 (2011).
3. Vincent, F. B. et al. Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective. Ann. Rheum. Dis. 72, 165-178 (2013).
4. Wijbrandts, C. A. et al. The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor alpha expression in the synovium. Ann. Rheum. Dis. 67, 1139-1144 (2008).
5. Tak, P. P. A personalized medicine approach to biologic treatment of rheumatoid arthritis: a preliminary treatment algorithm. Rheumatology 51, 600-609 (2012).
6. Cui, J. et al. Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritis. PLoS Genet. 9, e1003394 (2013).
7. Stahl, E. A. et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat. Genet. 42, 508-514 (2010).
8. Wray, N. R., Goddard, M. E. & Visscher, P. M. Prediction of individual genetic risk to disease from genome-wide association studies. Genome Res. 17, 1520-1528 (2007).
9. Wray, N. R. et al. Pitfalls of predicting complex traits from SNPs. Nat. Rev. Genet. 14, 507-515 (2013).
10. Daetwyler, H. D., Villanueva, B. & Woolliams, J. A. Accuracy of predicting the genetic risk of disease using a genome-wide approach. PLoS ONE 3, e3395 (2008).
11. Costello, J. C. et al. A community effort to assess and improve drug sensitivity prediction algorithms. Nat. Biotechnol. 32, 1-103 (2014).
12. Marbach, D. et al. Wisdom of crowds for robust gene network inference. Nat. Methods. 9, 796-804 (2012).
13. Margolin, A. A. et al. Systematic analysis of challenge-driven improvements in molecular prognostic models for breast cancer. Sci. Transl. Med. 5, 181re1 (2013).
14. Plenge, R. M. et al. Crowdsourcing genetic prediction of clinical utility in the rheumatoid arthritis responder challenge. Nat. Genet. 45, 468-469 (2013).
15. Prevoo, M. L. L. et al. Modified disease activity scores that include twenty-eightjoint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 38, 44-48 (1995).
16. van Gestel, A. M. et al. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum 39 (1996).
17. Yang, J. et al. Common {SNPs} explain a large proportion of the heritability for human height. Nat Genet. 42, 565-569 (2010).
18. Yang, J., Lee, S. H., Goddard, M. E. & Visscher, P. M. GCTA: a tool for genomewide complex trait analysis. Am. J. Hum. Genet. 88, 76-82 (2011).
19. Chhibber, A. et al. Genomic architecture of pharmacological efficacy and adverse events. Pharmacogenomics 15, 2025-2048 (2014).
20. Maki-tanila, A. & Hill, W. G. Influence of gene interaction on complex trait variation with multi-locus models. Genetics 198, 355-367 (2014).
21. Okser, S. et al. Regularized machine learning in the genetic prediction of complex traits. PLoS Genet. 10, e1004754 (2014).
22. Wray, N. R., Yang, J., Goddard, M. E. & Visscher, P. M. The genetic interpretation of area under the ROC curve in genomic profiling. PLoS Genet. 6, e1000864 (2010).
23. Kruppa, J., Ziegler, A. & Konig, I. R. Risk estimation and risk prediction using machine-learning methods. Hum. Genet. 131, 1639-1654 (2012).
24. Postmus, I. et al. Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins. Nat. Commun. 5, 5068 (2014).
25. Takeuchi, F. et al. A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose. PLoS Genet. 5, e1000433 (2009).
26. Tantisira, K. G. et al. Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma. N. Engl. J. Med. 365, 1173-1183 (2011).
27. Pappas, D. A., Kremer, J. M., Reed, G., Greenberg, J. D. & Curtis, J. R. Design characteristics of the CORRONA CERTAIN study: a comparative effectiveness study of biologic agents for rheumatoid arthritis patients. BMC Musculoskelet. Disord. 15, 113 (2014).
28. Stolovitzky, G., Prill, R. J. & Califano, A. Lessons from the DREAM2 challenges: a community effort to assess biological network inference. Ann. N. Y. Acad. Sci. 1158, 159-195 (2009).
29. Rasmussen, C. E. & Williams, C. K. I. Gaussian Processes for Machine Learning (The MIT Press, 2006).
30. Starmans, M. H. W., Fung, G., Steck, H., Wouters, B. G. & Lambin, P. A simple but highly effective approach to evaluate the prognostic performance of gene expression signatures. PLoS ONE 6, e28320 (2011).
31. Whalen, S. & Pandey, G. A Comparative Analysis of Ensemble Classifiers: Case Studies in Genomics. in 13th IEEE International Conference on Data Mining (ICDM) 807-816 (IEEE, 2013).
32. Wolpert, D. H. Stacked generalization. Neural Net. 5, 241-259 (1992).
33. Ting, K. M. & Witten, I. H. Issues in stacked generalization. J. Artif. Intell. Res. 10, 271-289 (1999).
34. Maher, B. Personal genomes: the case of the missing heritability. Nature 456, 18-21 (2008).
35. Frazer, K. A., Murray, S. S., Schork, N. J. & Topol, E. J. Human genetic variation and its contribution to complex traits. Nat. Rev. Genet. 10, 241-251 (2009).
36. Manolio, T. A. et al. Finding the missing heritability of complex diseases. Nature 461, 747-753 (2009).
37. Moore, J. H., Asselbergs, F. W. & Williams, S. M. Bioinformatics challenges for genome-wide association studies. Bioinformatics 26, 445-455 (2010).
38. Zeng, P. et al. Statistical analysis for genome-wide association study. Jpn. J. Clin. Oncol. 45, 1023-1028 (2015).
39. Klaasen, R. et al. The relationship between synovial lymphocyte aggregates and the clinical response to infliximab in rheumatoid arthritis: a prospective study. Arthritis Rheum. 60, 3217-3224 (2009).
40. Choi, I. Y. et al. MRP8/14 serum levels as a strong predictor of response to biological treatments in patients with rheumatoid arthritis. Ann. Rheum. Dis. 1-9 (2013).
41. Howie, B. N., Donnelly, P. & Marchini, J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 5, e1000529 (2009).
42. Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559-575 (2007).
43. Price, A. L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904-909 (2006).
44. Choy, E. et al. Genetic analysis of human traits in vitro: drug response and gene expression in lymphoblastoid cell lines. PLoS Genet. 4, e1000287 (2008).
45. Warnes, G., Duffy, D., Man, M., Qiu, W. & Lazarus, R. GeneticsDesign: Functions for designing genetics studies. R package version 1.32.0 (2010).
46. Bella, A., Ferri, C., Hernandez-Orallo, J. & Ramirez-Quintana, M. On the effect of calibration in classifier combination. Appl. Intell. 38, 566-585 (2013).
47. Hall, M. et al. The WEKA data mining software: an update. SIGKDD Explor. Newsl. 11, 10-18 (2009).
48. John, G. H. & Langley, P. Estimating continuous distributions in Bayesian classifiers. Proc. Eleven. Conf. Uncertain. Artif. Intell. 338-345 (1995).